|
|
|
| Engineered Yeast Cell for Producing Zeaxanthin |
| MEI Xue-ang1, CHEN Yan1, WANG Rui-zhao1, XIAO Wen-hai1,2, WANG Ying1,2, LI Xia1,2, YUAN Ying-jin1,2 |
1. Department of Pharmaceutical Engineering, School of Chemical Engineering and Technology, Tianjin University;Key Laboratory of Systems Bioengineering, Ministry of Education, Tianjin 300072, China;
2. SynBio Research Platform, Collaborative Innovation Center of Chemical Science and Engineering, School of Chemical Engineering and Technology, Tianjin 300072, China |
|
|
|
Abstract For heterologous synthesize natural carotenoid zeaxanthin in microorganism,a β-carotene producing Saccharomyces cerevisiae was chozen as the host cell to construct engineered yeast with synthetic biology method. The key enzymes β-carotene hydroxylase encoding gene CrtZ from nine sources were integrated in the chromosomal, separately. As the result, the strain carrying CrtZ from Erwinia uredovora achieved the highest titer of zeaxanthin. Moreover, the conversion from farnesyl pyrophosphate (an important precursor for terpenoid natural products) to farnesol was reduced by knocking out gene Lpp1 and Dpp1, providing more precursors for zeaxanthin synthesis. The zeaxanthin yield increased 1.27 fold (from 29 mg/L to 36.8 mg/L) accordingly. Furthermore, a titer of zeaxanthin was achieved as 96.2 mg/L in shake-flask through increasing the CrtZ gene copy number and regulating its promoter's activity,which is the highest reported microbial titer known.
|
|
Received: 13 January 2016
Published: 16 March 2016
|
|
|
|
|
| [1] Ding M Z, Yan H F, Li L F, et al. Biosynthesis of taxadiene in Saccharomyces cerevisiae:selection of geranylgeranyl diphosphate synthase directed by a computer-aided docking strategy. PloS One, 2014, 9(10):e109348.
[2] Du H X, Xiao W H, Wang Y, et al. Engineering Yarrowia lipolytica for campesterol overproduction. PloS One, 2016, 11(1):e0146773.
[3] Lian J, Si T, Nair N U, et al. Design and construction of acetyl-CoA overproducing Saccharomyces cerevisiae strains. Metabolic Engineering, 2014, 24:139-149.
[4] Ajikumar P K, Xiao W H, Tyo K E, et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science, 2010, 330(6000):70-74.
[5] Sajilata M G, Singhal R S, Kamat M Y. The carotenoid pigment zeaxanthin-a review. Comprehensive Reviews in Food Science and Food Safety, 2008, 7(1):29-49.
[6] Nishino H, Murakoshi M, Tokuda H, et al. Cancer prevention by carotenoids. Archives of Biochemistry and Biophysics, 2009, 483(2):165-168.
[7] Moeller S M, Jacques P F, Blumberg J B. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. Journal of the American College of Nutrition, 2000, 19(5):522-527.
[8] Li X R, Tian G Q, Shen H J, et al. Metabolic engineering of Escherichia coli to produce zeaxanthin. Journal of Industrial Microbiology & Biotechnology, 2015, 42(4):627-636.
[9] Beuttler H, Hoffmann J, Jeske M, et al. Biosynthesis of zeaxanthin in recombinant Pseudomonas putida. Applied Microbiology and Biotechnology, 2011, 89(4):1137-1147.
[10] Sun J, Shao Z Y, Zhao H M, et al. Cloning and characterization of a panel of constitutive promoters for applications in pathway engineering in Saccharomyces cerevisiae. Biotechnology and Bioengineering, 2012,109(8):2082-2092.
[11] Liang J, Ning J C, Zhao H M. Coordinated induction of multi-gene pathways in Saccharomyces cerevisiae. Nucleic Acids Research,2013,41(4):1-10.
[12] Gietz R D, Schiestl R H. Transforming yeast with DNA. Methods in Molecular and Cellular Biology, 1995, 5(5):255-269.
[13] Scaife M A, Ma C A, Ninlayarn T, et al. Comparative analysis of β-carotene hydroxylase genes for astaxanthin biosynthesis. Journal of Natural Products, 2012, 75(6):1117-1124.
[14] Fraser P D, Miura Y, Misawa N. In vitro characterization of astaxanthin biosynthetic enzymes. Journal of Biological Chemistry, 1997, 272(10):6128-6135.
[15] Westfall P J, Pitera D J, Lenihan J R, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proceedings of the National Academy of Sciences, 2012, 109(3):e111-e118.
[16] Faulkner A, Chen X, Rush J, et al. The LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae. Journal of Biological Chemistry, 1999, 274(21):14831-14837.
[17] Takahashi S, Yeo Y, Greenhagen B T, et al. Metabolic engineering of sesquiterpene metabolism in yeast. Biotechnology and Bioengineering, 2007, 97(1):170-181.
[18] Xie W P, Ye L D, Lv X M, et al. Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae. Metabolic Engineering,2015,28:8-18.
[19] Farhi M, Marhevka E, Masci T, et al. Harnessing yeast subcellular compartments for the production of plant terpenoids. Metabolic Engineering, 2011, 13(5):474-481.
[20] Zhang L, Gong Y F, Liu X D, et al. Cloning and expression analysis of β-carotene hydroxylase gene(chyb) from Dunaliella salina. Journal of Agricultural Biotechnology, 2013, 21(8):920-930.
[21] Liu D, Du J, Zhao G R, et al. Applications of synthetic biology in medicine and energy. CIESC J, 2011, 62(9):2391-2397.
[22] Hammer K, Mijakovic I, Jensen P R. Synthetic promoter libraries-tuning of gene expression. Trends in Biotechnology, 2006, 24(2):53-55.
[23] Siegl T, Tokovenko B, Myronovskyi M, et al. Design construction and characterisation of a synthetic promoter library for fine-tuned gene expression in actinomycetes. Metabolic Engineering, 2013,19:98-106.
[24] Paddon C J, Westfall P J, Pitera D J, et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature, 2013, 496(7446):528-532. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
